ACELYRIN, INC.

ACELYRIN is a late-stage clinical biopharma company focused on accelerating the development and delivery of transformative medicines for patients. They are exploring innovative approaches in immunology, aiming to make a clinically meaningful difference for patients relative to the standard of care. They are led by a team of veteran biopharma executives with exceptional track records of developing and commercializing transformative therapies.

ACELYRIN prioritizes a culture of "Courageous Caring" placing patients first and embracing collaboration. They actively investigate the potential of izokibep and lonigutamab in various diseases, with a commitment to developing and commercializing clinically meaningful therapies that can dramatically transform patients' lives. They are also committed to building strong, innovative, and diverse teams, fostering a welcoming and inclusive work environment.

ACELYRIN, INC. offers unlimited PTO and two annual company shutdowns, allowing employees to manage their time and take time off as needed. This demonstrates a commitment to employee well-being and a flexible work environment, although specific details about remote work options or flexible schedules are not mentioned.

ACELYRIN offers a comprehensive and competitive benefits package that prioritizes employee well-being. This includes fully-paid medical, dental, and vision coverage for employees, competitive costs for family members, HSA/FSA accounts, commuter benefits, parental leave, PTO, gym access, a 401k plan, paid holidays, life and disability insurance, pet insurance, unlimited PTO, team builders, and two annual company shutdowns.

ACELYRIN is a late-stage clinical biopharma company focused on accelerating the development and delivery of transformative medicines for patients. They are driven by a sense of urgency to identify, acquire, and accelerate the development of clinically meaningful therapies that address unmet needs in various diseases. ACELYRIN's mission is to build a different kind of biopharma company that invests in, develops, and commercializes life-changing drug therapies, putting patients first and prioritizing collaboration, innovation, and a sense of urgency in all their endeavors.

ACELYRIN promotes a culture of "Courageous Caring," prioritizing patient needs and fostering a collaborative, innovative environment where diverse teams work with a sense of urgency to develop and commercialize life-changing therapies. They emphasize a "we're all in this together" mentality, recognizing that the collective efforts of their employees can make a significant difference in the lives of patients.

ACELYRIN prioritizes diversity, equity, and inclusion by cultivating a community centered around "Courageous Caring." This means placing patients first and embracing a collaborative environment where everyone feels included and valued. The company actively fosters and hires talent from diverse backgrounds, demonstrating respect for employees of various identities. This commitment is reflected in their leadership team, workplace celebrations, and benefits package, which caters to the needs of a diverse workforce.